# Gefitinib versus pemetrexed as second‐line treatment in patients with nonsmall cell lung cancer previously treated with platinum‐based chemotherapy (KCSG‐LU08‐01)

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/gefitinib-versus-pemetrexed-as-second-line-treatment-in-patients-with-nonsmall/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Jong‐Mu Sun,Ki Hyeong Lee,Sang‐we Kim,Ki Hyeong Lee,Young Joo Min,Hwan‐Jung Yun,Hoon Kyo Kim,Hong Song,Yeul Hong Kim,Bong‐Seog Kim,In Gyu Hwang,Keehyun Lee,Sook Jung Jo,Won Jae Lee,Jin Seok Ahn,Keunchil Park,Myung‐Ju Ahn,for the Korean Cancer Study Group (KCSG) |
| Citations | 92 |
| DOI | 10.1002/cncr.27630 |
| Fields | Medicine |
| Open Access | true |
| OA Status | bronze |
| OA URL | https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/cncr.27630 |
| OpenAlex ID | https://openalex.org/W1571650151 |
| PMID | 22674612 |
| Type | article |
| Year | 2012 |

## Paper authors

- [Jin Seok Ahn](https://scholariq.org/researchers/jin-seok-ahn-2/)

## Paper journal

- [Cancer](https://scholariq.org/journals/cancer/)

## Paper primary topic

- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)

## Paper topics

- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)
- [Lung Cancer Diagnosis and Treatment](https://scholariq.org/topics/lung-cancer-diagnosis-and-treatment/)
- [Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis](https://scholariq.org/topics/interstitial-lung-diseases-and-idiopathic-pulmonary-fibrosis/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.